Measurement of sVEGF R1 and PlGF in serum: Comparing prototype assays from Beckman Coulter, Inc. to R&D systems microplate assays

Hypertension in Pregnancy

Volumn 30, Issue 1, 2011, Pages 18-27

  Wothe, Donald ^a   Gaziano, Emanuel ^a   Sunderji, Shiraz ^b   Romero, Roberto ^c   Kusanovic, Juan Pedro ^c   Rogers, Linda ^d   Hodges Savola, Cheryl ^d   Roberts, Sean ^d   Wassenberg, James ^d  

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

^b TOLEDO HOSPITAL   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d Beckman Coulter Inc   (United States)

Author keywords

Angiogenesis; Placental Growth Factor; Preeclampsia; sFlt 1; Soluble Vascular Endothelial Growth Factor

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ACCURACY; ARTICLE; ASSAY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; MALE; NORMAL HUMAN; PREDICTIVE VALUE; PREGNANT WOMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; FEMALE; HUMANS; IMMUNOASSAY; MALE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79952949639     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903322881     Document Type: Article

References (22)

1. Bersinger NA, Odegard RA. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand 2004; 83:37-45. (Pubitemid 38121729)
2. Unal ER, Robinson CJ, Johnson DD, Chang EY. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. Am J Obstet Gynecol 2007; 197:211-214.
3. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrin Metabol 2004; 89:770-775. (Pubitemid 38269892)
4. Robinson CJ, Johnson DD, Chang EY, Armstrong DM, Wang W. Evaluation of placenta growth factor and soluble fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 2006; 195:255-259. (Pubitemid 43927517)
5. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee KY, Goncalves LF, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 2004; 190:1541-1547.
6. Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Arai F, et al. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007; 30:151-159. (Pubitemid 46541789)
7. Teixeira PG, Cabral AC, Andrade SP, Reis ZS, da Cruz LP, Pereira JB, et al. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertens Preg 2008; 27:65-73. (Pubitemid 351302216)
8. McKeeman GC, Ardill JES, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (VEGFR-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 2004; 191:1240-1246. (Pubitemid 39421577)
9. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences. J Clin Endocrinol Metab 2003; 88:5555-5563. (Pubitemid 37452769)
10. Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and superimposed preeclampsia on chronic glomerulonephritis. Am J Obstet Gynecol 2006; 194:551-556. (Pubitemid 43183715)
11. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk for preeclampsia. N Engl J Med 2004; 350:672-683. (Pubitemid 38364626)
12. Krauss T, Pauer HU, Augustin HG. Prospective analysis of placental growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hyperten Preg 2004; 23:101-111. (Pubitemid 38445556)
13. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitundinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Maternal-Fetal Neonatal Med 2008; 21:9-23.
14. Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet.Gynecol 2007; 196:239-236.
15. Salahuddin S, Lee Y, Vadnais M, Sachs BP, Karumanchi SA, Lim K. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynecol 2007; 197:28.e1-28.e1-6.
16. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1502-1504.
17. Maynard SE, Moore Simas TA, Solitro MJ, Rajan A, Crawford S, Soderland P, Meyer B. Circulating angiogenic factors in singleton vs. multiple-gestation pregnancies. Am J Obstet Gynecol 2008; 200e1-200e7.
18. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6(4): 389-395. (Pubitemid 30208155)
19. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188:177-182. (Pubitemid 36135616)
20. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658. (Pubitemid 36278583)
21. Christinger HW, Fuh G, de Vos AM, Wiesmann C. The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1. Biol Chem 2004; 279(11):10382-10388. (Pubitemid 38372646)
22. Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Hyun Mee Ryu MH. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol 2008; 111:1403-1409.